Metabolic and behavioral effects of neurofibromin result from differential recruitment of MAPK and mTOR signaling
PLOS Genetics · 05.03.2026 · 22 (3) · e1012061
DOI: 10.1371/journal.pgen.1012061 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, online erschienen am 05.03.2026. Verfasst von Valentina Botero und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience and Pharmacology, University of Iowa, Iowa City, Iowa, United States of America. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Neurofibromin 1, Drosophila Proteins, Neurofibromatosis 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Neurological Disorders and Stroke, U.S. Department of Defense, Roy J. Carver Charitable Trust.
Abstract (Originalsprache)
Neurofibromatosis type 1 results from mutations in the NF1 gene and its encoded neurofibromin protein. This condition produces multiple symptoms, including tumors, behavioral alterations, and metabolic changes. Molecularly, neurofibromin mutations affect Ras activity, influencing multiple downstream signaling pathways, including MAPK (Raf/MEK/ERK) and PI3K/Akt/mTOR signaling. This pleiotropy raises the question of which pathways could be targeted to treat the disease symptoms, and whether different phenotypes driven by neurofibromin mutations exhibit similar or diverging dependence on the signaling pathways downstream of Ras. To test this, we examined metabolic and behavioral alterations in the genetically tractable Drosophila neurofibromatosis type 1 model. In vivo genetic analysis revealed that behavioral effects of neurofibromin were mediated by MEK signaling, with no necessity for Akt. In contrast, metabolic effects of neurofibromin were mediated by coordinated actions MEK/ERK and Akt/mTOR/S6K/4E-BP signaling. At the systemic level, loss of neurofibromin dysregulated metabolism via molecular effects in interneurons and muscle. These changes were accompanied by altered muscle mitochondria morphology, with no concomitant changes in neuronal ultrastructure or neuronal mitochondria. Overall, this suggests that neurofibromin mutations affect multiple signaling cascades downstream of Ras, which differentially affect metabolic and behavioral neurofibromatosis type 1 phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neuroscience and Pharmacology, University of Iowa, Iowa City, Iowa, United States of America.
- Program in Neuroscience and Behavior, Mount Holyoke College, South Hadley, Massachusetts, United States of America.
- Stead Family Department of Pediatrics, University of Iowa, Iowa City, Iowa, United States of America.
- Iowa Neuroscience Institute, University of Iowa, Iowa City, Iowa, United States of America.
- FOE Diabetes Research Center, University of Iowa, Iowa City, Iowa, United States of America.
ORCID-Profile: Valentina Botero, Anneke Knauss, Ethan Rosendahl, Kenneth J Colodner, Seth M Tomchik
Förderung
- National Institute of Neurological Disorders and Stroke
- U.S. Department of Defense
- Roy J. Carver Charitable Trust
Zitieren
APA
Botero, V., Barrios, J., Knauss, A., Dahlen, G., Rosendahl, E., Colodner, K. J., & Tomchik, S. M. (2026). Metabolic and behavioral effects of neurofibromin result from differential recruitment of MAPK and mTOR signaling. PLOS Genetics, 22(3), e1012061. https://doi.org/10.1371/journal.pgen.1012061
Vancouver
Botero V, Barrios J, Knauss A, Dahlen G, Rosendahl E, Colodner KJ, et al. Metabolic and behavioral effects of neurofibromin result from differential recruitment of MAPK and mTOR signaling. PLOS Genetics. 2026;22(3):e1012061. doi:10.1371/journal.pgen.1012061
BibTeX
@article{Botero2026,
author = {Botero, Valentina and Barrios, Jenifer and Knauss, Anneke and Dahlen, Greta and Rosendahl, Ethan and Colodner, Kenneth J and Tomchik, Seth M},
title = {Metabolic and behavioral effects of neurofibromin result from differential recruitment of MAPK and mTOR signaling},
journal = {PLOS Genetics},
year = {2026},
volume = {22},
number = {3},
pages = {e1012061},
doi = {10.1371/journal.pgen.1012061}
}
EUVIMED